These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2735236)

  • 21. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
    Ujiie T
    Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of cellular and humoral response against Tuberculin and antigen 85 complex during intravesical treatment with BCG of superficial bladder cancer.
    Zlotta A; Drowart A; van Vooren JP; Simon J; Schulman CC; Huygen K
    Acta Urol Belg; 1994 Sep; 62(3):63-8. PubMed ID: 7976857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experimental study on the antitumor activity of regional lymph nodes during immunotherapy].
    Kawata H
    Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1479-89. PubMed ID: 6521727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of adjunctive immunotherapy in superficial bladder cancer.
    Fujita K
    Cancer; 1987 Jun; 59(12):2027-30. PubMed ID: 3567865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrocardiogram studies on cancer patients treated with OK-432, a streptococcal preparation with potent biological response modifier activities.
    Torisu M; Goya T; Hayashi Y; Tanaka J; Sugisaki T; Yoshida T
    J Biol Response Mod; 1989 Dec; 8(6):665-75. PubMed ID: 2689599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Randomized controlled study of OK-432 in the treatment of cancerous pleurisy].
    Urata A; Nishimura M; Ota K
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1497-503. PubMed ID: 6409006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of selective intra-arterial infusion of OK-432 against renal cell cancers].
    Fujioka T; Tanji S; Koike H; Kumagai K; Suzuki K; Aoki H; Banya Y; Kubo T; Ohhori T
    Hinyokika Kiyo; 1987 Jun; 33(6):832-7. PubMed ID: 3673835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunotherapy of terminal-stage malignant tumors with the immunopotentiator OK-432--a comparison between SU-PS test-responder and -nonresponder patients].
    Yagi Y; Yagi S; Ichiki H
    Gan No Rinsho; 1987 Jun; 33(7):815-21. PubMed ID: 3302349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sequential combination therapy with alpha interferon and OK-432 (streptococcal preparation) against advanced renal cell carcinoma].
    Marumo K; Mura M; Deguchi N; Baba S; Jitsukawa S; Nakazono M; Tazaki H
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2434-9. PubMed ID: 3729498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of OK-432 on the lymphnode metastasis of MCA-sarcoma cell lines: a new therapeutic approach.
    Inoh A; Kodama Y; Yokoro K
    Hiroshima J Med Sci; 1989 Dec; 38(4):213-9. PubMed ID: 2637250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on the enhancement of anti-tumor activity in patients with cervical cancer by local administration of OK-432].
    Yamada Y; Yamamoto K; Wakita K; Shiraki S; Noda K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3427-31. PubMed ID: 3789753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of antitumor activity of OK-432 (picibanil) by Triton X-114 phase partitioning.
    Hashimoto M; Takashige K; Furuyashiki M; Yoshidome K; Sano R; Kawamura Y; Ijichi S; Morioka H; Koide H; Oku N; Moriya Y; Kusumoto S; Suda Y
    Int Immunopharmacol; 2008 Jan; 8(1):12-9. PubMed ID: 18068095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of combined immunotherapy using two different BRMs; OK-432 and IL-2-cultured lymphocytes].
    Kan N; Hori T; Ohgaki K; Inamoto T; Kodama H; Tobe T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1298-306. PubMed ID: 3488027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432.
    Hironaka K; Yamaguchi Y; Okita R; Okawaki M; Nagamine I
    Anticancer Res; 2006; 26(5B):3701-7. PubMed ID: 17094388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of various administration routes of the streptococcal preparation, OK-432, with regard to their in vivo effect by lymphocytes proliferation assay].
    Kimura Y; Toki H; Okabe K; Fujii M; Tamai M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):95-100. PubMed ID: 3942400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of orally administered streptococcal preparation, OK-432 on murine solid tumors and its absorption from the gut.
    Nio Y; Shiraishi T; Tsuchitani T; Tobe T; Sugawara Y; Saito M; Kamiyama H
    In Vivo; 1989; 3(5):307-13. PubMed ID: 2519870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T
    Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunity of gut-associated lymphoid tissue and the role of the oral immunotherapy in multi-disciplinary treatment of the digestive organ cancer].
    Nio Y; Tobe T
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1436-8. PubMed ID: 2586435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.